Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine Gene Expression in LGL Leukemia
NCT00363779Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jun 2006
- Primary completion
- Nov 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in large granular lymphocytic leukemia (LGLL), sponsored by National Cancer Institute. Started Jun 2006; status: terminated.
02
Drugs
cyclosporine
03
Conditions
large granular lymphocytic leukemia (LGLL)
Beyond the preview
Go deeper on NCT00363779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363779.